Hainan Haiyao Co., Ltd.
000566.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.11B
Close$
Share Statistics
| Market cap | $6.11 Billion |
|---|---|
| Enterprise Value | $8.71 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.33 |
| Beta | 0.21 |
| Outstanding Shares | 1,297,365,126 |
Return
| Return on Equity | 366.91% |
|---|---|
| Return on Assets | -8.54% |
| Return on Invested Capital | -15.08% |
Valuation & Multiples
| P/E Ratio | -12.95 |
|---|---|
| PEG | -25.49 |
| Price to Sales | - |
| Price to Book Ratio | -4.22 |
| Enterprise Value to Revenue | 12.4 |
| Enterprise Value to EBIT | -35.11 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | -22.73 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hainan Haiyao Co., Ltd.
1,738 employees
CEO: Chao Ma Hainan Haiyao Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. Its products include cephalosporin series, gastrointestinal series, oncology series, cochlear implant series, acti...